World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
58
Citations
9550
World Ranking
2114
National Ranking
22

Naomi Goldfinger publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Naomi Goldfinger sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 99 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Naomi Goldfinger D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Naomi Goldfinger sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Naomi Goldfinger is affiliated with the Weizmann Institute of Science in Israel. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Within these domains, their work focuses on several subfields including Molecular Biology, Physiology, Oncology, and Biotechnology.

The scientist's research encompasses a range of topics related to cellular and molecular mechanisms. These include:

  • Advanced biosensing and bioanalysis techniques
  • Telomeres, Telomerase, and Senescence
  • Congenital heart defects research
  • Cancer-related Molecular Pathways
  • Cancer Research and Treatments
  • Ubiquitin and proteasome pathways

Naomi Goldfinger has contributed to recent publications that explore critical biological processes and disease mechanisms. These recent papers are:

  • "Egr1 regulates regenerative senescence and cardiac repair," published in 2024 in Nature Cardiovascular Research
  • "Mutant p53 reactivation restricts the protumorigenic consequences of wild type p53 loss of heterozygosity in Li-Fraumeni syndrome patient-derived fibroblasts," published in 2024 in Cell Death and Differentiation

These publications have been cited in subsequent research, reflecting engagement within the scientific community.

Collaborations have involved frequent coauthors with whom Naomi Goldfinger has published multiple times. These coauthors include:

  • Varda Rotter
  • Lingling Zhang
  • Jacob Elkahal
  • Tianzhen Wang
  • Racheli Rimmer

Naomi Goldfinger's work appears regularly in scientific journals such as Nature Cardiovascular Research and Cell Death and Differentiation, indicating a focus on cardiovascular biology and cell death mechanisms.

Best Publications

  • Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis.

    G. Shaulsky;N. Goldfinger;Avri Ben-Ze'ev;V. Rotter

  • Meth A fibrosarcoma cells express two transforming mutant p53 species.

    Eliyahu D;Goldfinger N;Pinhasi-Kimhi O;Shaulsky G

  • Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues

    Gilad Landan;Netta Mendelson Cohen;Zohar Mukamel;Amir Bar

  • Activated p53 suppresses the histone methyltransferase EZH2 gene

    Xiaohu Tang;Michael Milyavsky;Igor Shats;Neta Erez

  • Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome.

    Varda Rotter;Dov Schwartz;Einat Almon;Naomi Goldfinger

  • Nuclear localization is essential for the activity of p53 protein.

    G Shaulsky;N Goldfinger;M S Tosky;A J Levine

  • Regulation of AIF expression by p53

    P Stambolsky;L Weisz;I Shats;Y Klein

  • Involvement of wild-type p53 in pre-B-cell differentiation in vitro.

    Gad Shaulsky;Naomi Goldfinger;Alpha Peled;Varda Rotter

  • p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner

    Alina Molchadsky;Igor Shats;Naomi Goldfinger;Meirav Pevsner-Fischer

  • Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53.

    Andrei Seluanov;Vera Gorbunova;Ayellet Falcovitz;Alex Sigal

  • Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes

    D Schwartz;N Goldfinger;V Rotter

  • Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.

    Xi-Song Ke;Yi Qu;Kari Rostad;Wen-Cheng Li;Wen-Cheng Li

  • Mutant p53 protein expression interferes with p53-independent apoptotic pathways.

    Runzhao Li;Patrick D. Sutphin;Dov Schwartz;Devorah Matas

  • Prolonged Culture of Telomerase-Immortalized Human Fibroblasts Leads to a Premalignant Phenotype

    Michael Milyavsky;Igor Shats;Neta Erez;Xiaohu Tang

  • Retraction: Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function.

    Lilach Weisz;Amir Zalcenstein;Perry Stambolsky;Yehudit Cohen

  • Mutant p53 R175H upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells

    I. Kogan-Sakin;Y. Tabach;Y. Buganim;A. Molchadsky

  • p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation

    Ran Brosh;Reut Shalgi;Atar Liran;Gilad Landan

  • Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.

    Gad Shaulsky;Naomi Goldfinger;Varda Rotter

  • Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells

    Rachel Sarig;Noa Rivlin;Ran Brosh;Chamutal Bornstein

  • Testicular tissue-specific expression of the p53 suppressor gene.

    Einat Almon;Naomi Goldfinger;Ahuva Kapon;Dov Schwartz

Frequent Co-Authors

Varda Rotter
Varda Rotter Weizmann Institute of Science
Moshe Oren
Moshe Oren Weizmann Institute of Science
Gad Shaulsky
Gad Shaulsky Baylor College of Medicine
Lars A. Akslen
Lars A. Akslen University of Bergen
Curtis C. Harris
Curtis C. Harris National Institutes of Health
Iris Barshack
Iris Barshack Sheba Medical Center
Arnold J. Levine
Arnold J. Levine Institute for Advanced Study
Guillermina Lozano
Guillermina Lozano The University of Texas MD Anderson Cancer Center
Zohar Yakhini
Zohar Yakhini Technion – Israel Institute of Technology
Gideon Rechavi
Gideon Rechavi Sheba Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in molecular biology? There are diverse online degree options and career pathways that can complement your scientific education. For those interested in advanced healthcare roles, direct entry msn programs offer non-nurses a fast track to a Master of Science in Nursing, opening doors in research, clinical leadership, and bioinformatics.

Comparing institutions is crucial for quality and value. Explore the differences between capella university vs wgu rn to bsn programs to find flexible learning environments that fit your schedule and career goals. Additionally, bridge programs like bsn to msn online pathways help registered nurses advance their credentials quickly, often while working.

Quality matters, so consider non profit online universities for accredited programs with strong reputations and student support. Overall, online degrees provide flexible, accessible opportunities to deepen your scientific expertise and expand your career opportunities in health, laboratory work, or research.

Best Scientists Citing Naomi Goldfinger

Trending Scientists

Recently Published Articles